Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case–control study in Italy
DSpace/Manakin Repository
Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case–control study in Italy
| Title: | Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case–control study in Italy |
| Author: |
Rossi, M; Edefonti, V; Parpinel, M; Lagiou, P; Franchi, M; Ferraroni, M; Decarli, A; Zucchetto, A; Serraino, D; Dal Maso, L; Negri, E; La Vecchia, C
Note: Order does not necessarily reflect citation order of authors. |
| Citation: | Rossi, M., V. Edefonti, M. Parpinel, P. Lagiou, M. Franchi, M. Ferraroni, A. Decarli, et al. 2013. “Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case–control study in Italy.” British Journal of Cancer 109 (7): 1914-1920. doi:10.1038/bjc.2013.447. http://dx.doi.org/10.1038/bjc.2013.447. |
| Full Text & Related Files: |
3790154.pdf (160.2Kb; PDF) 
|
| Abstract: | Background: Because of their antioxidant and antimutagenic properties, flavonoids may reduce cancer risk. Some flavonoids have antiestrogenic effects that can inhibit the growth and proliferation of endometrial cancer cells. Methods: In order to examine the relation between dietary flavonoids and endometrial cancer, we analysed data from an Italian case–control study including 454 incident, histologically confirmed endometrial cancers and 908 hospital-based controls. Information was collected through a validated food-frequency questionnaire. We applied data on food and beverage composition to estimate the intake of flavanols, flavanones, flavonols, anthocyanidins, flavones, isoflavones, and proanthocyanidins. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from multiple logistic regression models conditioned on age and study centre and adjusted for major confounding factors. Results: Women in the highest quartile category of proanthocyanidins with ⩾3 mers vs the first three quartile categories had an OR for endometrial cancer of 0.66 (95% CI=0.48–0.89). For no other class of flavonoids, a significant overall association was found. There was a suggestion of an inverse association for flavanones and isoflavones among women with body mass index <25 kg m−2, and, for flavanones, among parous or non-users of hormone-replacement therapy women. Conclusion: High consumption of selected proanthocyanidins may reduce endometrial cancer risk. |
| Published Version: | doi:10.1038/bjc.2013.447 |
| Other Sources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790154/pdf/ |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347472 |
| Downloads of this work: |
This item appears in the following Collection(s)
-
SPH Scholarly Articles [6281]
Contact administrator regarding this item (to report mistakes or request changes)
